Versartis (VSAR)

Download button icon Download

Versartis (VSAR): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

[NEUTRAL]: Neither buyer or seller are in control at the close of the market for Versartis. There has been 3 consecutive days of prices closing in the middle part of the trading range for VSAR showing a lack of direction in the first timeframe & highlights the lack of commitment from both the buyers & sellers. Over the last 12 months there has been 4 trading days with the closing price in the middle part of the range giving a confirmation ratio of 1.5%. Over the last month there has been 4 trading days with the closing price in the middle range giving a confirmation ratio of 30.8%. Currently this quarter, closing price has spent 4 days in the middle price range giving a ratio of 0.1x.



Where the closing price fall within the day’s trading range highlights whether are in control.

[Calculations] Close Today Versus Range Today (CTRT):
1) When the closing price is near the high of the day buyers were in control at the close of the trading session;
2) When the closing price is near the low of the day sellers were in control at the close of the trading session;
3) When the closing price is near the middle of the day’s range where neither the buyers or sellers were in control at the close of the trading session;


PROFILE: Versartis (VSAR)


Stock Exchange: NASDAQ
Company: Versartis
Ticker Codes: | VSAR | NASDAQ:VSAR |

About Versartis (NASDAQ:VSAR):

Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. It is developing somavaratan, a long-acting recombinant human growth hormone for the treatment of growth hormone deficiency. The company was founded in 2008 and is headquartered in Menlo Park, California.

Top 10:

Close vs Range

Download button icon Download
Company Close Change (%) Volume Value Signal
BCOM B Communications 10.5 9 1,699 0 NEUTRAL
UEPS Net 1 UEPS Technologies 7.23 7.3 641,115 0 NEUTRAL
MDCA Mdc Partners 4.6 7 1,096,476 0 NEUTRAL
AGEN Agenus Inc 2.1 5 1,380,455 0 NEUTRAL
MESO Mesoblast Ads 6.63 3.1 94,244 0 NEUTRAL
WDC Western Digital 60.05 2.8 5,127,208 0 NEUTRAL
AQXP Aquinox Pharmaceutic 2.88 2.5 370,576 0 NEUTRAL
CLDX Celldex Therapeutics 0.43 2.4 840,248 0 NEUTRAL
ACET Aceto 2.99 2.4 116,876 0 NEUTRAL
IPHS Innophos 45.58 2.2 108,123 0 NEUTRAL
back to top